Form 4 holding
Chief Executive Officer, Director
Inhibrx Biosciences, Inc.
- Security class
- Common Stock
- Shares / value
- 745,588
- Estimated value
- $63,941,626
- Report date
- 14 Oct 2026
- Price
- $85.76
- Ownership
- By the Lappe Family Trust